These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging. Ballester M; Bordes R; Tazelaar HD; Carrió I; Marrugat J; Narula J; Billingham ME J Am Coll Cardiol; 1998 May; 31(6):1357-61. PubMed ID: 9581733 [TBL] [Abstract][Full Text] [Related]
11. Patterns of myocardial cell adhesion molecule expression in human endomyocardial biopsies after cardiac transplantation. Induced ICAM-1 and VCAM-1 related to implantation and rejection. Herskowitz A; Mayne AE; Willoughby SB; Kanter K; Ansari AA Am J Pathol; 1994 Nov; 145(5):1082-94. PubMed ID: 7977640 [TBL] [Abstract][Full Text] [Related]
12. Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis. Puig M; Ballester M; Matías-Guiu X; Bordes R; Carrió I; Kolodgie FD; Pons C; García A; Aymat MR; Marrugat J; Brossa V; Campreciós M; Padró JM; Caralps JM; Virmani R; Prat J; Narula J J Nucl Cardiol; 2000; 7(2):132-9. PubMed ID: 10796002 [TBL] [Abstract][Full Text] [Related]
14. Utility of troponin assays for exclusion of acute cellular rejection after heart transplantation: A systematic review. Fitzsimons S; Evans J; Parameshwar J; Pettit SJ J Heart Lung Transplant; 2018 May; 37(5):631-638. PubMed ID: 29426716 [TBL] [Abstract][Full Text] [Related]
15. Cardiac troponin I: a marker of acute heart rejection in infant and child heart recipients? Siaplaouras J; Thul J; Krämer U; Bauer J; Schranz D Pediatr Transplant; 2003 Feb; 7(1):43-5. PubMed ID: 12581327 [TBL] [Abstract][Full Text] [Related]
16. Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejection. Moran AM; Lipshultz SE; Rifai N; O'Brien P; Mooney H; Perry S; Perez-Atayde A; Lipsitz SR; Colan SD J Heart Lung Transplant; 2000 Aug; 19(8):756-64. PubMed ID: 10967269 [TBL] [Abstract][Full Text] [Related]
17. Serum Levels of miR-155, miR-326, and miR-133b as Early Diagnostic Biomarkers for the Detection of Human Acute Heart Allograft Rejection in Comparison with Serum Cardiac Troponin T. Esmaeili-Bandboni A; Bagheri J; Bakhshandeh AR; Mohammadnejad J; Sadroddiny E Heart Surg Forum; 2018 Mar; 21(2):E101-E107. PubMed ID: 29658868 [TBL] [Abstract][Full Text] [Related]
18. Troponin T and I are not reliable markers of cardiac transplant rejection. Mullen JC; Bentley MJ; Scherr KD; Chorney SG; Burton NI; Tymchak WJ; Koshal A; Modry DL Eur J Cardiothorac Surg; 2002 Aug; 22(2):233-7. PubMed ID: 12142191 [TBL] [Abstract][Full Text] [Related]
19. Inability of serum myocyte death markers to predict acute cardiac allograft rejection. Wang CW; Steinhubl SR; Castellani WJ; Van Lente F; Miller DP; James KB; Young JB Transplantation; 1996 Dec; 62(12):1938-41. PubMed ID: 8990392 [TBL] [Abstract][Full Text] [Related]
20. Anti-skeletal muscle glycolipid antibodies in human heart transplantation as markers of acute rejection. Correlation with endomyocardial biopsy. Laguens RP; Argel MI; Chambó JG; Vigliano CA; San Martino JA; Perrone SV; Favaloro RR Transplantation; 1996 Jul; 62(2):211-6. PubMed ID: 8755818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]